Home » FDA’s New Device Reclassification Process

FDA’s New Device Reclassification Process

Who will benefit

Regulatory affairs
Product lifecycle management professionals
Legal counsel
Compliance officers
Quality and risk management professionals

02Jun
Implementing Clinical and Performance Evaluation Reports for Your Medical Device: Best Practices for Getting them Right
03Jun
Biosimilars on the Rise: The Latest on FDA’s Guidelines and Guidances
04Jun
Pharmaceutical Social Media Advertising: Expand Your Reach and Prevent Regulatory Mistake
09Jun
Medical Devices and Digital Health After COVID-19: Implications for the Industry and Your Business
10Jun
Medical Device Corrections and Removals, Recalls and Closures: Best Practices for Call Center Operations and Notice
16Jun
Dealing with FCPA and Other Investigations Under the New Normal

Featured Products

Featured Stories

The Revised ICH E8: A Guide to New Clinical Trial Requirements